IndiaInfoline » Markets » AJANTPHARM

Ajanta Pharma Ltd - Share Price

AJANTPHARM

Open

976.50

Prev. Close

979.40

Turnover (lac.)

468

Day's High

994.60

Day's Low

976.50

52 Week's High

1,204.45

52 Week's Low

825.00

Book Value

273

Face Value

2

Mkt Cap (Cr.)

8,634

P/E

22.58

EPS

43.77

Divi. Yield

0.92

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd427.0039.17102,451.60823.160.643,215.0198.33
Dr Reddys Laboratories Ltd2,908.7519.2148,330.521,365.100.693,435.30852.70
Divis Laboratories Ltd1,806.3037.2047,952.92352.830.891,403.92266.77
Cipla Ltd447.9015.2936,098.73737.380.673,230.08209.72
Biocon Ltd289.20116.7334,740.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The companys business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded... More

Registered Office

Ajanta House,Charkop Kandivli (W),Mumbai, Maharashtra,400067

Tell. : +91-22-66061000/1204/1203
Website : http://www.ajantapharma.com
Email : info@ajantapharma.com

Registrar Office

C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA

Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in

View

- <

Reco. Price

Nov 06,2019 03:37 PM

Target Price

Target Returns:

0.00%

Result Express

Ajanta Pharma Ltd's Q3FY19 consolidated net profit declines 54.63% yoy to Rs66.90cr: Misses Estimates

Dec 10, 2019 04:40 AM

The company’s consolidated revenue in the quarter stood at Rs485.11cr, down 17.36% yoy and 10.84% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    05 Nov 2019

    Effective. Date

    15 Nov 2019

    Divi. Type

    Interim

    Divi.(%)

    650

    Divi. Amt.

    13

    Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held ... More

  • Purpose

    Board Meeting

    Exp. Date

    05 Nov 2019

    Annc. Date

    22 Oct 2019

    AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sche... More